[An Effective Treatment of Relapsed Leiomyosarcoma with Fourth-Line Trabectedin].

Author: KatoShunsuke, NozakiYumi, TakagiTatsuya, YamaguchiShigeo

Paper Details 
Original Abstract of the Article :
A 56-year-old women underwent retroperitoneal leiomyosarcoma resection in December 2011. In July 2015, CT showed multiple liver metastases, and she received first-line chemotherapy treatment with doxorubicin. After 2 courses of doxorubicin, her performance status deteriorated; therefore, she was tre...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/30914533

データ提供:米国国立医学図書館(NLM)

A Case Study: Trabectedin as a Fourth-Line Treatment for Relapsed Leiomyosarcoma

Leiomyosarcoma is a rare and aggressive type of cancer that can be challenging to treat. This case study describes the journey of a patient diagnosed with leiomyosarcoma who received a fourth-line treatment with trabectedin. The patient had previously undergone surgery and received several other chemotherapy treatments, but the cancer continued to spread. Trabectedin was a last resort, and the results were promising. The patient experienced a reduction in liver metastases, and the disease was controlled for a significant period. This case study provides valuable insights into the potential of trabectedin as a treatment option for relapsed leiomyosarcoma. It highlights the importance of exploring all available treatment options, even in challenging cases.

Hope for Relapsed Cancers: Trabectedin's Potential

Trabectedin has shown promise in treating various cancers, including leiomyosarcoma. This case study provides a real-world example of its effectiveness in a challenging situation. It offers hope for patients facing relapsed cancers and encourages further research into this drug's potential.

Navigating the Journey with Cancer

This case study highlights the emotional and physical challenges faced by individuals battling cancer. It also showcases the resilience and determination of patients and the dedication of medical professionals in finding solutions. It emphasizes the importance of perseverance and hope in the face of adversity.

Dr.Camel's Conclusion

The desert may seem vast and unforgiving, but even in the harshest conditions, life finds a way. This case study serves as a testament to the incredible resilience of the human spirit and the power of hope in overcoming seemingly insurmountable challenges. Trabectedin's success in this case offers a beacon of hope for others facing similar battles. It's a reminder that even in the darkest of times, there is always a glimmer of light waiting to be found.

Date :
  1. Date Completed 2019-08-23
  2. Date Revised 2019-08-23
Further Info :

Pubmed ID

30914533

DOI: Digital Object Identifier

30914533

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.